当前位置：首页 > 文献互助 > 互助详情

Discovery of Novel Orally Bioavailable Polθ Inhibitors with Arylalkyne Scaffolds for Targeting HR-Deficient Cancers复制

用户6X7Ch8WUQ_gI 1个月前 119 10 已完结

1. 系统已在2026-02-08 10:18:13对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: https://doi.org/10.1021/acs.jmedchem.5c01977复制

文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c01977复制

其他信息:

出版社: American Chemical Society (ACS)
作者: Jinyang Zhang; Xiaomeng Sun; Qichen Zhou; Yingying Wei; Biao Chen; Junhui Jiao; Yu Du; Shepherd Wufoyrwoth; Haoze Chi; Yi Yang; Ping Wei; Yungen Xu; Yi Zou; Qihua Zhu
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c01977

上一篇：Advanced biomimetic nanofiltration membranes for lithium recovery with anti-janus charge structure

下一篇：Fluorescent dyes in the era of super-resolution imaging: new opportunities, challenges, and evolution

互助时间线

2026-02-03 21:31:37 [完结求助]

楼主确认了数据探险家应助的文件是正确的, 求助状态变成 已完结

2026-02-01 10:18:13 [上传文件]

数据探险家上传了文件(pdf 10.82 MB), 求助状态变成 待确认

2026-01-31 17:10:38 [发起求助]

最新发布的求助

Programming memristor arrays with arbitrarily high precision for analog computing 59分钟前
Receptor activity-modifying protein and small molecule modulation of the gastric inhibitory polypeptide receptor 1小时前
Clinical probability-adjusted (CPA) D-dimer thresholds for the exclusion of venous thromboembolism (VTE) in the emergency department 1小时前
A synthetic humanized camelid single-domain antibody targeting VEGF exhibits in vitro antiangiogenic effects 1小时前
Five things to know about ... D-dimer testing in clinical practice 1小时前
Application of a diagnostic strategy for patients with suspected pulmonary embolism in a middle-income country 1小时前
Structure-Based Discovery of a New LpxH-Targeted Chemotype with Activity against Klebsiella pneumoniae 1小时前
Discovery of a Hydroxamic Acid-Based HDAC11 Isoform-Selective Inhibitor with Oral Anti-AML Potency 1小时前
Design and Synthesis of Pyrrolo[3,4- d ]pyrimidine-Based ATR Degraders for Effective Treatment of Colorectal Cancer in Mouse Model 1小时前
Development of Dihydroquinoxalinone-Based Dual CDK6/BET Inhibitors for Triple-Negative Breast Cancer Therapy 1小时前
Discovery of XYD270 as a Potent, Selective, and Orally Efficacious BRD9 PROTAC for Cancer Therapy 1小时前
Discovery of Clinical Candidate IAG933, a Potent YAP-TEAD PPI Disrupter 1小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com